InvestorsHub Logo
Followers 47
Posts 12023
Boards Moderated 0
Alias Born 09/12/2017

Re: bluefish1 post# 216072

Friday, 12/23/2022 4:33:52 PM

Friday, December 23, 2022 4:33:52 PM

Post# of 232562
Lemme explain again...in simpler terms- Is the SEC's investigation into Cytodyn continuing or not? SEC says it is...its not over, but but but continuing to investigate Cytodyn.

Item 8.01 – Other Events
This is the place where companies may report anything that they believe is important but is not specifically required elsewhere in the 8-K.

https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins/how-read-8

Looks material to me...and to top it off CYDY says theyre done with NP but but but continue to abide by his employment agreement right?

RIGHT?

On January 24, 2022, the Board of Directors terminated the employment of the Company’s President and Chief Executive Officer, Nader Z. Pourhassan, Ph.D. (the “former CEO”), and removed him as an officer of the Company. Under the terms of his employment agreement, Dr. Pourhassan was also deemed to resign, without any further action or notice, from all positions held with the Company and its subsidiaries, including, without limitation, as a member of the Board. Under the terms of the severance agreement and in accordance with the employment agreement, as amended, with the former CEO, the Company is obligated to pay severance within 60 days of separation, as a lump sum, in the amount of 12 months of salary in effect at the time of separation, and another six months of salary paid in monthly installments beginning 180 days after the termination date.


And speaking of deflection...what happened to items (a) (c) (d) in the latest 8k filing?

Sold for nice gains already. LOL! Thats what they all say...show us the proof.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News